allogeneic bone marrow transplantation from
CMV antigenemia in unrelated BMT would lead on its own unrelated donors but doubts about an to an artefactual increase in the diagnosis of CMV disease increase in CMV-associated disease due to the increasing probability of association with signs or symptoms not related to CMV, but frequently seen in this setting (nephropathy, cytopenias, etc) . No difference was found in the so-called serious CMV-associated disease Takenaka et al 1 compared the incidence of CMV infection (detected by blood antigenemia) and disease between (CMV pneumonia and enteritis) between related and unrelated transplants, which were the only cases that fulfil the patients with allogeneic related and unrelated BMT, finding an increased incidence of infection and CMV disease in standard criteria of CMV disease. So, finally the conclusion of the article has to be that in the unrelated group. The data relating to CMV infection (presented with clarity and precision) are very interesting, spite of an increased incidence of CMV infection in patients with unrelated donors, no increase in CMV disease was in particular the high incidence of CMV infection in unrelated BMT patients without acute GVHD grade II-IV and found, although the number of unrelated BMTs was small. The similar incidence of CMV pneumonia in related and the higher level of CMV antigenemia in unrelated transplants compared with one-locus HLA-mismatched related in unrelated BMT groups suggests a similar good predictive value for CMV antigenemia in both settings. Criteria should donors which, as suggested by the authors, elicited discussion of different alloantigen stimulation pathways.
be more standardised in studies of CMV in BMT. Nonetheless, the CMV disease definitions and conclusions drafted about it as given in the article merit some comment.
R 6 presence of antigenemia plus two of whatever combination of features such as leukopenia (Ͻ3000 leukocytes/l), thrombocytopenia (Ͻ100 000/l), atypical lymphocytosis (Ͼ20% of peripheral white cells), References hepatitis (у2.5 times the upper limit of normality in the absence of serologic evidence of hepatitis B, hepatitis A or 1 Takenaka K, Gondo H, Tanimoto K et al. Increased incidence VEB; hepatitis C not included), gastrointestinal bleeding, of cytomegalovirus (CMV) infection and CMV-associated disunexplained fever for 3 or more days or nephropathy, ease after allogeneic bone marrow transplantation from unreamong others. In our opinion, in the BMT setting the appli- ambiguous term, and although renal lesions due to CMV 749-753. have been described 7 it is quite a rare diagnosis in BMT
